Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Langermann S, Möllby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, Strouse R, Schenerman MA, Hultgren SJ, Pinkner JS, Winberg J, Guldevall L, Söderhäll M, Ishikawa K, Normark S, Koenig S.

J Infect Dis. 2000 Feb;181(2):774-8.

PMID:
10669375
2.

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.

Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S.

Vaccine. 1999 Feb 26;17(7-8):904-14.

PMID:
10067697
3.

Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.

Palaszynski S, Pinkner J, Leath S, Barren P, Auguste CG, Burlein J, Hultgren S, Langermann S.

Dev Biol Stand. 1998;92:117-22.

PMID:
9554264
4.

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.

Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ.

Science. 1997 Apr 25;276(5312):607-11.

5.

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK.

J Exp Med. 1994 Dec 1;180(6):2277-86.

6.

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG.

J Exp Med. 1993 Jul 1;178(1):197-209.

7.

Identification of a zinc finger protein that inhibits IL-2 gene expression.

Williams TM, Moolten D, Burlein J, Romano J, Bhaerman R, Godillot A, Mellon M, Rauscher FJ 3rd, Kant JA.

Science. 1991 Dec 20;254(5039):1791-4.

PMID:
1840704
8.

New use of BCG for recombinant vaccines.

Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, et al.

Nature. 1991 Jun 6;351(6326):456-60.

PMID:
1904554
9.

Advantages of firefly luciferase as a reporter gene: application to the interleukin-2 gene promoter.

Williams TM, Burlein JE, Ogden S, Kricka LJ, Kant JA.

Anal Biochem. 1989 Jan;176(1):28-32.

PMID:
2785354
10.

Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression.

Williams TM, Eisenberg L, Burlein JE, Norris CA, Pancer S, Yao D, Burger S, Kamoun M, Kant JA.

J Immunol. 1988 Jul 15;141(2):662-6.

PMID:
2838551

Supplemental Content

Loading ...
Support Center